Disclosure certainty 4/5 debate potential 1/5

Doyle: Array raised $1.3M pre-seed on a $7M SAFE cap

Matt Doyle · Typeform On Steroids Hits $50k in MRR up from $20k 1 year Ago · Dec 13, 2022 · at 13:18

Matt Doyle, founder and CEO of Array, discusses the terms of his company's prior $1.3 million fundraising round with Nathan Latka.

0:00 / 0:02
720p mp4 · rendered on demand · StarZero watermark
“Seven million cap.”

quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →

More from Matt Doyle

Insight
Doyle: Per-seat SaaS licensing breaks down at high enterprise volumes
“When it goes up to that area, like sometimes these industries, it doesn't, per seat licensing doesn't always make sense. And that's the thing for any founder is probably going to find is software as a service makes sense to a point, but then as soon as you get…”
Matt Doyle Dec 13, 2022 ▶ 3:48 Typeform On Steroids Hits $50k in MRR up from $20k 1 year Ago
Disclosure
Doyle: Array's largest customer pays over $20,000 per month
“The biggest is 20,000 plus a month.”
Matt Doyle Dec 13, 2022 ▶ 3:37 Typeform On Steroids Hits $50k in MRR up from $20k 1 year Ago
Assertion Not checkable as stated
Doyle: Array enterprise accounts scale from $300 to over $1k/mo in 12 months
“So typically a customer will start around the 300 dollar mark and then scale up. So the enterprise market that we've been focusing on now, they scale over and above that thousand dollar mark within about 12 months.”
Matt Doyle Dec 13, 2022 ▶ 8:00 Typeform On Steroids Hits $50k in MRR up from $20k 1 year Ago
Assertion Not checkable as stated
Doyle: Array grew MRR from $10k to $50k in 18 months
“Yeah, so when we raised that, like, VC money about a year and a half ago, we were making about 10 K a month. And now, about 50 K a month.”
Matt Doyle Dec 13, 2022 ▶ 9:05 Typeform On Steroids Hits $50k in MRR up from $20k 1 year Ago
Disclosure
Doyle: Array delayed fundraising and cut costs due to frothy 2022 market
“We started a little bit this year, and it was just a bit frothy, so we decided to cut costs, cut some expenses that were around the business, and get these, like, larger enterprise clients that were starting to upgrade, just get them in the door, get them to w…”
Matt Doyle Dec 13, 2022 ▶ 13:28 Typeform On Steroids Hits $50k in MRR up from $20k 1 year Ago
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 2,600 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.